The Globe and Mail reports in its Friday, Nov. 7, edition that National Bank Financial analyst Mohamed Sidibe continues to rate Cameco "outperform." The Globe's David Leeder writes in the Eye On Equities column that Mr. Sidibe gave his share target a $5 boost to $145. Analysts on average target the shares at $138.59. Cameco's third quarter results missed expectations, but Mr. Sidibe remains optimistic about its future, emphasizing its focus on an $80-billion (U.S.) nuclear reactor deal with the U.S. government. Mr. Sidibe says: "Overall, the 2025 outlook was reiterated and sales outlook into Q4/25 firmed up. The upside potential remains at Westinghouse as evidenced by commentary made on the call and Cameco remains disciplined on the contracting front as it awaits for better pricing terms to arise, which it views as inevitable. The partnership with Brookfield Asset Management and the U.S. government is expected to accelerate Westinghouse's growth, with the IPO target serving as a potential milestone. ... Cameco remains well positioned to benefit from tightening supply dynamics and higher uranium prices, supported by its long-term contract portfolio and strong balance sheet."